The Voice2Voice Program is available for patients or caregivers to connect with others who are interested in, or currently using Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, for the treatment of primary immunodeficiency (PI) or chronic inflammatory demyelinating polyneuropathy (CIDP).
Please enter the following information, which will be used as part of the verification process for enrollment. (* required)